Osaic Holdings’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $26.3K | Sell |
475
-185
| -28% | -$10.2K | ﹤0.01% | 5155 |
|
2025
Q1 | $31.9K | Buy |
660
+68
| +11% | +$3.29K | ﹤0.01% | 5005 |
|
2024
Q4 | $22.9K | Buy |
592
+414
| +233% | +$16K | ﹤0.01% | 5223 |
|
2024
Q3 | $8.01K | Sell |
178
-292
| -62% | -$13.1K | ﹤0.01% | 5863 |
|
2024
Q2 | $16.3K | Sell |
470
-2,081
| -82% | -$72.1K | ﹤0.01% | 5430 |
|
2024
Q1 | $73.8K | Buy |
2,551
+2,270
| +808% | +$65.7K | ﹤0.01% | 4457 |
|
2023
Q4 | $6.44K | Sell |
281
-31
| -10% | -$710 | ﹤0.01% | 5990 |
|
2023
Q3 | $5.2K | Buy |
+312
| New | +$5.2K | ﹤0.01% | 6189 |
|
2022
Q2 | – | Sell |
-57
| Closed | -$1K | – | 7360 |
|
2022
Q1 | $1K | Hold |
57
| – | – | ﹤0.01% | 6918 |
|
2021
Q4 | $2K | Hold |
57
| – | – | ﹤0.01% | 6900 |
|
2021
Q3 | $1K | Sell |
57
-173
| -75% | -$3.04K | ﹤0.01% | 6987 |
|
2021
Q2 | $11K | Buy |
230
+37
| +19% | +$1.77K | ﹤0.01% | 5989 |
|
2021
Q1 | $5K | Sell |
193
-966
| -83% | -$25K | ﹤0.01% | 6116 |
|
2020
Q4 | $24K | Buy |
1,159
+616
| +113% | +$12.8K | ﹤0.01% | 5016 |
|
2020
Q3 | $11K | Sell |
543
-9,540
| -95% | -$193K | ﹤0.01% | 5204 |
|
2020
Q2 | $178K | Buy |
10,083
+10,000
| +12,048% | +$177K | ﹤0.01% | 3233 |
|
2020
Q1 | $1K | Buy |
+83
| New | +$1K | ﹤0.01% | 5792 |
|